AstraZeneca (AZN) Gets a Buy from Goldman Sachs
Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £155.58. The ...
Business Insider1 个月
GlaxoSmithKline (GSK) Gets a Hold from Goldman Sachs
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target of £16.90. The company’s shares closed today at p1,321. ...